Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — Q3 FY23 Earnings Presentation
27 slides from Nath Bio-genes (india)'s earnings presentation, Feb 14, 2023
Slide 1: Exchange filing cover letter for results presentation
14th February 2023 The Manager-Listing The Manager-Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Dear Sir/Madam, Subject- Presentation
Slide 2: One Seed, Many Lives - Q3 & 9MFY23 Investor Presentation
One Seed, Many Lives Sustainable Value Creation Q3 & 9MFY23 Investor Presentation 1
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Strategy for Sustainable Value Creation
Strategy for Sustainable Value Creation 1 TAILOR MADE 2 SUPERIOR 3 Strong R&D 4 INVESTMENT PRODUCTS PRODUCT Focus GRADE . PERFORMANCE BALANCE SHEET Customized products to High Yield and Strong Bio-tech integrated Zero Long Term Debt address key farmer Pest and Disease innovation requirements Resista
Slide 5: Competitive Positioning in a Tough Sector
Competitive Positioning in a Tough Sector Focus Area Winning Strategies Product Selection • Focus on Cotton, Vegetables, • Build a dream-product basket Fodder Bajra with superior and diversified products • Empower Stakeholders; Build long-term, loyal, symbiotic • Build an Un-paralleled Supply relati
Slide 6: What our Business Delivered in Last 5 Years
What our Business Delivered in Last 5 Years Average Selling Price (Rs) is Increasing Revenue Growth (INR Cr) 279 CAGR 10.4% 982 192 480 211 128 FY18 FY22 Field Crops Vegetables FY18 FY22 5
Slide 7: Tailor Made Products
Tailor Made Products Understand key farmer requirements based on deep market research 1 Develop products to suits various agro climatic conditions 2 Focus on disease and pest resistance which automatically 3 results in higher yield 4 Stringent multistage trials before commercial development 6
Slide 8: Our Success Stories
Our Success Stories = — Super 27- Bajra
Slide 9: Sanket – #1
Sanket – #1 Market Need: • High level of resistance to sucking pest ✓ Only Bt-Cotton hybrid in the Market • Yield losses ✓ High customer retention ✓ Recognized by Indian Ministry of Agriculture for its consistent performance through repeated All India What our R&D Produced: Coordinated Trials ✓ Expe
Slide 10: Testimonials: Sanket
Testimonials: “Sanket” Farmers on “Sanket” “खर्च काम वाला कॉटन, कीड़े कण्ट्रोल में और खर्ाच भी कम ” “कीड़ा कम दवा कम और ज्यादा कपास ” 9
Slide 11: Super 27- Deep-Rooting into Bajra
Super 27- Deep-Rooting into Bajra Market Need • High Yielding dual Purpose Hybrids • Crop window exploitation Our R&D efforts ✓ Product is seeing strong traction ✓ Addressable market of 3000 tons • High level of blast tolerance ✓ NBIL is expected to gain 50% market share in • High biomass next two y
Slide 12: Testimonials: Super 27
Testimonials: “Super 27” Farmers on “Super 27” “इतने बड़े ससट्टे वाला बiजारा मैंने कभी दे खा नह ीं था। ससट्टा बहुत मजबत ू है और दाना भर भर के है ” “पपछले साल मुझे सुपर 27 के उत्पाद भेजते वक्त 100 रूपया प्रतत कक्वींटल ज्यादा समले, इनके दानोंका साइज और रीं ग दे सी टाइप है ” “डबल धमाके वाला बाजरा है - स
Slide 13: Akhand- Best Performing
Akhand- Best Performing Market Need • Very deep red colour fruits with better shelf life • Virus resistant hybrid • Higher Yield ✓ Strong demand seen in the market - Zero inventory left Our R&D Efforts ✓ Addressable market size - Rs 150cr • Shift from conventional breeding to Biotech- ✓ NBIL is expe
Slide 14: Testimonials: Akhand
Testimonials: “Akhand” Farmers on “ Akhand ” “ठोस और मजबूत फल, दरू भेजने के सलए जबरदस्त हैं! नुक्सान भी कम हैं” “लाल और टे स्ट फल, एक सामान साइज हैं” “एक जैसा फल और जबरदस्त नफा होता हैं” 13
Slide 15: Focussed on R&D
Focussed on R&D • Well Invested, DSIR • Produce Genetically Pure and Premium recognized R&D Innovation Quality Seeds Centers • Prioritise Disease and Pest resistance • Cold storage facilities, breeding warehouses, and conditioning godowns having a capacity of 20,000MT 02 03 • R&D Team of • Large and
Slide 16: Focussed on Shareholder Value Creation
Focussed on Shareholder Value Creation Growing Business Product Excellence Strong Positions in important crops Innovation and solution that drive productivity and create value for farmers Differentiated Customer Experience Margin Expansion Expanding market reach through new Growing EBITDA margins th
Slide 17: Q3 & 9MFY23 Performance
Q3 & 9MFY23 PERFORMANCE 16
Slide 18: Key Operating and Financial Highlights
Key Operating and Financial Highlights o Non-cotton, non-paddy portfolio contribution at 47% to revenues; Revenue growth of 12% in 9MFY23; Cotton volumes maintained o Company is moving towards hybrid paddy sales which is driving value growth; Cotton volumes would be maintained at last year levels Op
Slide 19: Segmental Revenue Contribution
Segmental Revenue Contribution 9MFY22 Revenue 9MFY23 Revenue INR 2,512 Mn INR 2,563 Mn Cotton, 30% Cotton, 33% Others, 38% Others, 47% Paddy, 23% Paddy, 29% Cotton Paddy Others Cotton Paddy Others • include: Jowar, Bajra, Maize, Mustard, Wheat 18
Slide 20: Segment wise Operating Performance
Segment wise Operating Performance Products Metric 9MFY23 9MFY22 YOY Growth FY22 Cotton Packets in lakhs 11.30 11.69 -3.5% 11.90 Paddy Quintals 46,196 56,106 -17.6% 59,176 Other Crops (Bajra, Quintals 33,738 34,730 -0.1% 29,963 Maize) Vegetables Quintals 1,833 1,193 53.6% 2929 19
Slide 21: Income Statement
Income Statement Particulars (INR Mn) Q3FY23 Q3FY22 9MFY23 9MFY22 Total Revenue 253 217 2,563 2,512 Gross Profit 157 144 1,384 1,297 Gross Margin (%) 62.1% 66.4% 53.9% 51.6% EBITDA 56 60 448 585 EBITDA Margin (%) 22.2% 27.6% 17.4% 23.3% Depreciation 7 6 20 19 Finance Cost 30 27 85 81 PBT 20 30 345 4
Slide 22: Appendix
APPENDIX
Slide 23: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet Net Debt (INR Mn) Net Worth (INR Mn) 6,133 5,576 5,420 888 5,076 4,692 679 659 576 3,033 478 363 207 1,071 1,213 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 -121 EBITDA Margin (%) PAT Margin (%) 18% 18% 21% 22% 17% 1
Slide 24: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent Mr. N Mr. Satish Nath Promoters are committed to sustainable Kagliwal Kagliwal MD growth and are working towards making Nath one Chairman of the best seeds company globally. Leadership Team Research & Product Development Nath leadership team shares th
Slide 25: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY22 FY21 FY20 Total Revenue 2,783 3076 2799 Gross Profit 1,544 1715 1536 Gross Margin (%) 56% 56% 55% EBITDA 373 667 547 EBITDA Margin (%) 13% 22% 20% Depreciation 31 28 14 Finance Cost 106 88 65 PBT (before exceptional)
Slide 26: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn)FY FY22 FY21 FY20 Liabilities FY22 FY21 FY20 Fixed Assets 2,449 2,469 2,460 Share Capital 190 190 190 Financial Assets 51 53 52 Reserves & Surplus 5,230 5,943 5,386 Other Non-current Assets 218 134 15 Long-Term Borrowings 7 7 3 Inventories 2,203 2,263 2,043 Lo
Slide 27: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja Monali Jain sheetal@GoIndiaadvisors.com monali@GoIndiaadvisors.com M:+91 97693 64166 M:+917597304020 26
Nath Bio-Genes (India) — Q3 FY23 Earnings Presentation on 6ix